Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Hyperkalaemia in the Cardiorenal Patient - Navigating Guidelines & Real-World Data
Author(s): Clara Bonanad Lozano , Anjay Rastogi Added: 8 months ago
Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Clara Bonanad (University Clinical Hospital of Valencia, ES) discuss the evolving management strategies of hyperkalaemia in heart failure and chronic kidney disease, in this short video series. In this three part discussion they cover the most recent guidelines from ACC, ESC and KDIGO, real-world evidence from the recent ZORA… View more

Heart Failure

Prevention & Chronic Conditions
HFA 24 Late-Breaker Discussion: The TITRATE-HF Study
Author(s): Jasper J Brugts , Harriette Van Spall Added: 10 months ago
HFA 24 - Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) joined onsite by Dr Jasper Brugts (Erasmus University Medical Centre, NL) to discuss the first results from the TITRATE-HF study.TITRATE-HF is a real-world multicenter longitudinal study which aims to assess drug sequencing strategies for guideline-directed medical therapy (GDMT) initiation in patients with de novo,… View more

Heart Failure
Implementing Heart Failure Guidelines with Collaborative Care
Start date: Aug 27, 2023 End date: Aug 27, 2023
Radcliffe Medical Education present a satellite symposium entitled ‘Implementing Heart Failure Guidelines with Collaborative Care’ at the ESC Congress 2023 in Amsterdam, NL. Join us in the Riga Lecture Room, or online, on Sunday 27 August 2023, from 12:45 to 13:45 CEST. This session, chaired by Prof Carolyn Lam (National Heart Centre Singapore, SG), provides an excellent opportunity for… View more

Heart Failure
ACC 23: Inflammatory Risk from Statin-Treated Patients
Author(s): Paul M Ridker Added: 1 year ago
ACC.23/WCC - We are joined by Dr Paul Ridker (Brigham and Women’s Hospital, US) to discuss the findings from a collaborative analysis of 31,197 patients to assess inflammatory risk in statin-treated patients. The PROMINENT, REDUCE-IT and STRENGTH trials were each large contemporary trials which implemented guideline-directed medical therapy, the findings of which were pooled in this study. The… View more

Prevention & Chronic Conditions
Optimising RAASi Management in Cardiorenal Patients: An Expert Roundtable
Author(s): Andrew Frankel , Shelley Zieroth , , et al Added: 10 months ago
In this on-demand version of the live roundtable, cardiologists Dr Shelley Zieroth (University of Manitoba, Winnipeg, CA) and Dr Aaron Wong (Princess of Wales Hospital, Wales, UK) join nephrologists Dr Andrew Frankel (Imperial College Healthcare NHS Trust, London, UK), and Dr Manish Sood (University of Ottawa, CA) to discuss the nuanced landscape of RAASi management in cardiorenal patients.In… View more

Heart Failure

Prevention & Chronic Conditions
B Hadley Wilson
Research Area(s) / Expertise:
Dr B HadleyWilson, is the president of the American College of Cardiology (2023-2024). Dr Wilson is an interventional cardiologist and executive vice chair at Sanger Heart and Vascular Institute/Atrium Health in Charlotte, North Carolina. He is also a Clinical Professor of Medicine at Wake Forest University School of Medicine. Dr Wilson is a graduate of Davidson College and Duke University School… View more
Overcoming the Challenges in Optimising GDMT in HF
Start date: May 21, 2023 End date: May 21, 2023
Radcliffe Medical Education is hosting a symposium entitled 'Overcoming the Challenges in Optimising GDMT in Heart Failure' at theHeart Failure Association (HFA)in Prague, CZ, on Sunday 21 May 2023 at 12:30 - 13:30 CEST. Add to your calendar. Overview In this symposium we join Dr Gianluigi Savarese (Karolinska Institute, Stockholm, SE), Dr Stephen Greene (Duke University School of Medicine,… View more

Heart Failure
THT 25: The RELIEVE-HF Study
Author(s): Gregg Stone Added: 1 month ago
THT Conference 2025 - Outcomes after heart failure patients were treated with an interatrial shunt show heart failure with reduced ejection fraction (HFrEF) patients had further benefit compared to heart failure with preserved ejection fraction (HFpEF) patients. The study's prediction model revealed four independent predictors of two-year adverse outcomes in HFrEF patients treated with medical… View more

Heart Failure
Heart Failure in Focus Podcast - Ep 6: Cardiorenal Care in Practice
Author(s): Muthiah Vaduganathan , Added: 2 years ago
In this month's episode, our host DrMuthiah Vaduganathan speaks with Dr Kieran McCafferty, Consultant Nephrologist at Barts NHS Health Trust London, and Senior Clinical Lecturer at Queen Mary University of London, about the growing need for effective management strategies in cardiorenal disease.After touching on the current epidemiology of co-existing CKD and heart failure (HF), Kieran gives a… View more

Heart Failure

Prevention & Chronic Conditions
ESC 24: The SENIOR RITA Trial
Author(s): Vijay Kunadian Added: 6 months ago
ESC Congress 2024 — No difference in cardiovascular outcomes between invasive and conservative strategies in elderly NSTEMI patients.Principal Investigator, Prof Vijay Kunadian (Newcastle upon Tyne Hospitals NHS Trust, UK) join us in London to discuss the key findings from the SENIOR RITA trial (NCT03052036; Newcastle-upon-Tyne Hospitals NHS Trust).The SENIOR-RITA trial is a multicenter, open… View more

Demographic

Prevention & Chronic Conditions